MarianneJeanetteDaviesNP

PubMed

• 7 citations
  Acute and Long-term Adverse Events Associated With Checkpoint Blockade.
  Marianne Davies> ;Seminars in Oncology Nursing. 2019 Sep 9
• 3 citations
  The prevalence and related factors associated with psychosocial distress among 420 hospitalised lung cancer patients in China: A case study.
  Hui Tan, Sijuan Chen, Elizabeth Ercolano, Mark Lazenby, Marianne Davies, Jianhua Chen, Ruth McCorkle> ;European Journal of Cancer Care. 2019 Jul 1
• 154 citations
  The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
  Julie R. Brahmer, Ramaswamy Govindan, Robert A. Anders, Scott J. Antonia, Sarah Sagorsky, Marianne Davies, Steven M. Dubinett, Andrea Ferris, Leena Gandhi, Edward B. G...> ;Journal for Immunotherapy of Cancer. 2018 Jul 17
• 7 citations
  How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to Know.
  Marianne Davies> ;Journal of the Advanced Practitioner in Oncology. 2016 Jul 1
• De-mystifying genes: identifying and managing hereditary cancer.
  Marianne Davies> ;ONS Connect. 2007 Jan 1
• Management of novel therapeutics' side effects: a nurse-centric model.
  Marianne Davies> ;ONS Connect. 2007 Jan 1
• Join now to see all

Journal Articles

• How checkpoint inhibitors are changing the treatment paradigm in solid tumors: what advanced practitioners in oncology need to know  
  Davies, M, J Adv Pract Oncol, 1/1/2016
• An advanced practice nurse coordinated multidisciplinary intervention for patients with late-stage cancer: a cluster randomized trial  
  McCorkle, R., Jeon, S., Ercolano, E., Lazenby, M., Reid, A., Davies, M., Viveiros, D. & Gettinger, S, Journal of Palliative Medicine, 1/1/2015
• Updates from ASCO 2014 and ESMO 2014  
  Herbst, R.S., Davies, M., & Kenney, J.T., Faculty Perspectives: Latest Treatment Advances for Individualized Care of NSCLC, 1/1/2015
• Enhancing peer review to support APN practice  
  Davies, M., Tucker, K., Dest, V., Lyons, C., Fitzsimons, S. & McCorkle, R, Oncology Nursing News, 1/1/2014
• New modalities of cancer treatment for NSCLC: focus on immunotherapy  
  Davies, M, Cancer Management and Research, 1/1/2014
• Journal club bridges research and practice, improving patient care  
  Davies, M., Fradkin, M. & Blasiak, E, Oncology Nursing News, 1/1/2013
• Perceptions of roles, practice patterns, and professional growth opportunities broadening the scope of advanced practice in oncology  
  McCorkle R, Lazenby M, Englehart C, Davies M, Sipples R, Ercolano E & Lyons C, CJON, 1/1/2012
• Transition to a New Cancer Care Delivery System: Opportunity for Empowerment of the Role of the Advanced Practice Provider  
  McCorkle R, Engelking C, Knobf MT, Lazenby M, Davies M, Sipples R, Ercolano E & Lyons C, J Adv Pract Oncol, 1/1/2012
• Expectoration of a Lung Metastasis in a Patient with Colorectal Carcinoma  
  Ghetie C, Davies M, Cornfeld D, Suh N & Saif W, Clinical Colorectal Cancer, 1/1/2008
• Rechallenge with Cisplatin in a Patient with Pancreatic Cancer Who Developed a Hypersensitivity Reaction to Oxaliplatin Is Skin Test Useful in this Setting?  
  Elligers K, Davies M, Sanchis D, Ferencz T and Saif W, Journal of the Pancreas, 1/1/2008
• Management of novel therapeutics’ side effects: a nurse-centric model  
  Davies, M, ONS Connect, 1/1/2007
• Advancing access to myeloma treatment: administration, side effects, and implications for survival  
  Davies, M, ONS News, 1/1/2006
• Strategies for Success: optimizing oral therapies in breast and colorectal cancer  
  Davies, M, ONS News, 1/1/2006
• Comparison of Health-related Quality of Life Questionnaires in Ambulatory Oncology  
  Cooley ME, McCorkle R, Knafl GJ, Rimer J, Barbieri MJ, Davies M, and Murren JR, Quality of Life Research, 1/1/2005
• Peer Viewpoint re: Prevention and Management of Cardiotoxicity from Antineoplastic Therapy, by Chanan-Khan A, Srinivasan S and Czuczman MS  
  Lekakis L, Davies M and Murren JR, Supportive Oncology, 1/1/2004
• A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer  
  Hobdy EM, Kraut E, Masters G, Blum K, McKeon A, Byrd B, Davies M, Beaulieu N and Murren J, Cancer Biology and Therapy, 1/1/2004
• Phase 1 Dose Escalation Trial of Weekley Docetaxel Plus Irinotecan in Patients with Advanced Cancer  
  Bleickardt E, Argiris A, Rich R, Blum K, McKeon A, Tara H, Zelterman D, Burtness B, Davies M, and Murren JR, Cancer Biology & Therapy, 1/1/2002
• Irinotecan and Taxane Combinations for Non-Small Cell Lung Cancer  
  Murren JR & Davies M, Cancer Biology & Therapy, 1/1/2001
• Rationale and Dose-Finding Studies of the Combination of Irinotecan and Taxane on a weekly Schedule  
  Murren JR, Blum K Gallipoli M, McKeon A & Rich R, Oncology, 1/1/2001
• CPT-11 and Paclitaxel: The Role of Non-Platinum Therapy in Non-Small Cell Lung Cancer  
  Gallipoli M and Murren JR, Advances in Lung Cancer, 1/1/2000
• Join now to see all

Books/Book Chapters

• Lung Cancer Choices 
  Chapter: Systemic Therapy for Non-Small Cell Lung Cancer (Chemotherapy, Targeted Therapy and Immunotherapy) 
  Davies, MCaring Ambassadors Program, Inc., Oregon City OREdition 3rd,2016
• Advanced Oncology Nursing Certification Review & Resource Manual 
  Chapter: Chapter 12: Cardiac and Pulmonary Toxicities 
  Davies, MEditors: B. Gobel, S. Triest-Robertson & W. Vogel.Oncology Nursing Society Press, Pittsburgh, PA2016
• Lung Cancer Choices 
  Chapter: Chemotherapy treatment of Non-Small Cell Lung Cancer 
  Davies, M. & Reid, ACaring Ambassadors Program, Inc., Oregon City, OREdition 2nd,2014
• Clinical Manual for the Oncology Advanced Practice Nurse 
  Chapter: Pleural Effusion 
  Davies, MEditors: D. Camp-Sorrell & R.A. Hawkins.Oncology Nursing Society, Pittsburgh, PAEdition 3rd,2014
• Clinical Manual for the Oncology Advanced Practice Nurse 
  Chapter: Pulmonary Embolism 
  Davies, MEditors: D. Camp-Sorrell & R.A. Hawkins.Oncology Nursing Society, Pittsburgh, PAEdition 3rd,2014
• Clinical Manual for the Oncology Advanced Practice Nurse 
  Chapter: Acute Renal Failure 
  Davies, MEditors: D. Camp-Sorrell & R.A. Hawkins.Oncology Nursing Society, Pittsburgh, PAEdition 3rd,2014
• Clinical Manual for the Oncology Advanced Practice Nurse 
  Chapter: Adrenal Metastasis 
  Davies, MEditors: D. Camp-Sorrell & R.A. Hawkins.Oncology Nursing Society, Pittsburgh, PAEdition 2nd,2006
• Clinical Manual for the Oncology Advanced Practice Nurse 
  Chapter: Benign Prostatic Hyperplasia 
  Davies, MEditors: D. Camp-Sorrell & R.A. Hawkins.Oncology Nursing Society, Pittsburgh, PAEdition 2nd,2006
• Site-Specific Cancer Series: Lung Cancer 
  Chapter: Lung Cancer Control 
  Davies, M., Houlihan, N. & Joyce, MEditors: N.G. Houlihan.Oncology Nursing Society Press, Pittsburgh, PA2004
• Contemporary Issues in Lung Cancer, A Nursing Approach 
  Chapter: Multidisciplinary Clinic Approach to Lung Cancer 
  Davies, MEditors: M. Haas.Bartlett Publishers, Sudbury, MA2003
• Principles and Practice of Supportive Oncology 
  Chapter: Cardiopulmonary Toxicity of Cancer Therapy 
  Davies, M., Murren, J.R. & Schultz, M.Z.Editors: A.M. Berger, R.D. Portenoy, & D.E. Weissman.Lippincott-Raven Publishers, New YorkEdition 2nd,2002
• Join now to see all

Abstracts/Posters

• Management of endocrinopathies associated with nivolumab and ipilimumab combination therapy in advanced melanoma and other solid tumors
  Davies, M., Wood, L.S., Rubin, K., Madden, K., Brennan, L., Dahl, N., Walker, D., Li, X. & Kottschade, L., JADPRO Live at APSHO, National Harbor, MD, 1/4/2016
• Management of gastrointestinal adverse events associated with nivolumab and ipilimumab combination therapy in advanced melanoma and other solid tumors
  Kottschade, L., Davies, M., Rubin, K., Madden, K., Dahl, N., Brennan, L., Walker, D., Li, X. & Wood, L, JADPRO Live at APSHO, National Harbor, MD, 1/4/2016
• Management of endocrinopathies associated with nivolumab and ipilimumab combination therapy in advanced melanoma and other solid tumors
  Davies, M., Wood, L.S., Rubin, K., Madden, K., Brennan, L., Dahl, N., Walker, D., Li, X. & Kottschade, L., Fifteenth International Kidney Cancer Symposium, Miami, FL, 1/4/2016
• Management of gastrointestinal adverse events associated with nivolumab and ipilimumab combination therapy in advanced melanoma and other solid tumors
  Kottschade, L., Davies, M., Rubin, K., Madden, K., Dahl, N., Brennan, L., Walker, D., Li, X. & Wood, L, Fifteenth International Kidney Cancer Symposium, Miami, FL, 1/4/2016
• Identification and management of cardio-pulmonary toxicities of targeted therapies –a multidisciplinary approach
  Davies, M., Altan, M., Chiang, A., Crowley, K., Dest, V., Duffield, E., Gerrish, H., Gettinger, S., Goldberg, S., Lilenbaum, R., Rowen, E. & Herbst, R, 16th Annual Targeted Treatment of Lung Cancer Meeting. International Association for the Study of Lung Cancer (IASLC), Santa Monica, CA, 1/1/2016
• Dermatologic complications of immune therapy: lessons learned from four case studies
  Duffield, E., Altan, M., Chiang, A., Davies, M., Dest, V., Gerrish, H., Gettinger, S., Goldberg, S., Lilenbaum, R., Rowen, E. & Herbst, R, 16th Annual Targeted Treatment of Lung Cancer Meeting. International Association for the Study of Lung Cancer (IASLC), Santa Monica, CA, 1/1/2016
• Development of the Peer Review Process for Advanced Practice Registered Nurses
  Davies, M., Tucker, K. & Fitzsimons, S., Joseph A. Zaccagnino Patient Safety and Clinical Quality Conference, Yale New Haven Health System, Bridgeport, CT, 1/19/2015
• Optimizing the Delivery of Patient Care with the Immune Checkpoint Inhibitor Nivolumab in Patients with Advanced Melanoma (MEL)
  Lingard, K., Davies, M. & Hodgetts, J, UKONS Annual Conference, Birmingham, United Kingdom, 1/13/2015
• Development and Implementation of a Peer Review Process for APRNs
  Davies, M. & Tucker, K, JADPRO Live at APSHO, Phoenix, AZ, 1/6/2015
• Identification and management of immune mediated toxicities associated with immune checkpoint inhibitors: utilizing a focused algorithm
  Davies, M., Dest, V., Gerrish, H., Rowen, E. & Duffield, E., 7th Annual Nursing Research and Evidence-Based Practice Conference, Yale-New Haven Hospital, New Haven, CT, 1/2/2015
• Development of the peer review process for advanced practice registered nurses
  Davies, M. & Tucker, K., 7th Annual Nursing Research and Evidence-Based Practice Conference, Yale-New Haven Hospital, New Haven, CT, 1/2/2015
• Enhancing Physical Wellbeing in Lung Cancer
  Davies, M, Journal of Thoracic Oncology, 1/1/2015
• Identification & Management of Unique Immune Mediated Toxicities
  Davies, M., Duffield, E. & Rowen, E., Journal of Thoracic Oncology, 1/1/2015
• Diagnosis and management of toxicities caused by immune checkpoint blockade
  Davies, M., Chiang, A., Dest, V., Duffield, E., Gerrish, H., Gettinger, S., Goldberg, S., Lilenbaum, R., Rowen, E. & Herbst, R., 15th Annual Targeted Treatment of Lung Cancer Meeting. International Association for the Study of Lung Cancer (IASLC), Santa Monica, CA, 1/1/2015
• Transforming peer review for advanced practice nurses
  Davies, M., Dest, V., Lyons, C. & Mc Corkle, R, Oncology Nursing Forum, 1/1/2014
• Immune checkpoint inhibitors managing unique immune related endocrine side effects
  Davies M, 14th Annual Targeted Treatment of Lung Cancer Meeting. International Association for the Study of Lung Cancer (IASLC), Santa Monica, CA, 1/1/2014
• Assessment of oncology advanced practice providers criteria for inclusion in a clinical ladder program to promote professional development in two academic medical centers
  Davies M & McDonnell T, Oncology Nursing Forum, 1/1/2012
• An advanced practice nurse-led oncology journal club to promote research dissemination
  Davies M, Fradkin M & Blasiak E, Sixteenth Annual Nursing Research & Evidenced-Based Practice Conference. The Connecticut Nursing Research Alliance Evidenced-Based Practice: Outcome-Focused Innovations, 1/1/2012
• “Smilow Society”- an oncology nursing journal club to promote research dissemination
  Davies M, Fradkin M & Blasiak E, Oncology Nursing Forum, 1/1/2012
• Prognostic impact of Extracapsular Extension in squamous cell carcinoma of the head and neck
  Baumgart M, Acevedo-Gadea C, Wang Z, Butta E, Davies M, Deshpande H, Decker R, Sasaki C, Judson B, Son Y, Herbst RS & Morgensztern, Journal of Clinical Oncology, 1/1/2012
• Prognostic impact of the AJCC staging in patients with squamous cell carcinoma of the oropharynx
  Acevedo-Gadea C, Baumgart M, Wang Z, Deshpande H, Davies M, Judson B, Decker R, Sasaki C, Herbst RS & Morgensztern D, Journal of Clinical Oncology, 1/1/2012
• Successful desensitization with cetuximab (CET) after hypersensitivity reaction (HSR) to panitumumab (PAN) and CET in patients with metastatic colorectal cancer
  Shah MM, Hotchkiss S, Shanley J, Davies M, Ferencz T, Syrigos K and Saif W, Journal of Clinical Oncology, 1/1/2008
• Successful re-challenge with panitumumab in patients with GI cancers who develop hypersensitivity reactions to cetuximab
  Potter V, Davies M, Peccerillo J and Saif W, Journal of Clinical Oncology, 1/1/2008
• Development and Implementation of Nurse Practitioner Mentorship Program
  Davies M, Oncology Nursing Forum, 1/1/2004
• Join now to see all

Lectures

• Immunotherapy in the Oncology Patient 
  Yale New Haven Health System: Yale New Haven Hospital. New Haven, CT - 1/29/2016
• Management of Patients Treated with Immunotherapy. Collaborative Practice in the Management of Cancer Patients with Non-Small Cell Lung Cancer 
  NYU Langone’s Perlmutter Cancer Center. New York, NY - 1/25/2016
• Management of Patients Treated with Immunotherapy. Collaborative Practice in the Management of Patients with Non-Small Cell Lung Cancer 
  University of Alabama at Birmingham Hospital. Birmingham, AL - 1/23/2016
• Immuno-Oncology: A New Era in NSCLC Therapy 
  Academy of Oncology Nurse & Patient Navigators. Chicago, IL - 1/22/2016
• Overview & Management of Patients with Immunotherapy 
  Lawrence & Memorial Hospital Cancer Center, Waterford, CT - 1/20/2016
• Management of Patients Treated with Cytotoxic Chemotherapy. Collaborative Practice in the Management of Patients with Non-Small Cell Lung Cancer 
  Levine Cancer Institute. Charlotte, NC - 1/17/2016
• Case Studies in Metastatic NSCLC and Metastatic HNSCC 
  Cancer Center at Beth Israel Deaconess Medical Center, Duxbury, MA - 1/15/2016
• The Rise of the Patient in Cancer Therapy: Value and Therapy Selection 
  BMLI. San Francisco, CA - 1/15/2016
• Lost in Transition 
  Yale Cancer Center & Smilow Cancer Center at Yale New Haven, New Haven, CT - 1/12/2016
• The Role of the Nurse and Nurse Practitioner with Targeted and Immunotherapy for Cancer 
  BMLI. San Francisco, CA - 1/10/2016
• Foundational Principles and Practical Application of Immunotherapies for Oncology Nurses and Pharmacists 
  Central Massachusetts ONS. Worcester, MA - 1/7/2016
• Oncology Nursing Perspectives on the Evolving Management of NSCLC 
  Orlando, FL - 1/25/2015
• Lung Cancer Update 
  Dorchester, MA - 1/24/2015
• Understanding the Immune System and Checkpoint Inhibitors in Solid Tumors: What Oncology Nurses Need to Know 
  Orlando, FL - 1/24/2015
• OPDIVO: A New Approach for Previously Treated Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC) 
  Orlando, FL - 1/24/2015
• Managing and Preventing Immune-Related Side Effects with Checkpoint Inhibition: What have we learned and how can we help out patients 
  BMLI. San Francisco, CA - 1/17/2015
• Optimizing the Delivery of Patient Care with the Immune Checkpoint Inhibitor Nivolumab in Patients with Advanced Melanoma (MEL) 
  Birmingham, United Kingdom - 1/13/2015
• Patient Encounters of the Difficult Kind 
  Yale Cancer Center & Smilow Cancer Center at Yale New Haven, New Haven, CT - 1/12/2015
• Enhancing Physical Wellbeing in Lung Cancer 
  Denver, CO - 1/9/2015
• Identification & Management of Unique Immune Mediated Toxicities 
  Denver, CO - 1/7/2015
• Advances in the Principles of Immunotherapy 
  Smilow Cancer Hospital at Yale New Haven - 1/1/2015
• Managing Immunotherapy Side Effects. Immunotherapy for Melanoma, Kidney & Lung 
  Chicago, IL - 1/26/2014
• Recognizing and Managing unique side effects and responses of immune therapy in lung cancer 
  San Francisco, CA - 1/18/2014
• Advanced Practice Nurse Council Development and Peer Review Integration 
  Middlesex, CT - 1/11/2014
• Utilizing a Strategic Planning Approach to Transform Peer Review for Advanced Practice Nurses 
  Yale-New Haven Hospital, New Haven, CT - 1/9/2014
• Join now to see all

Other

• Hepatotoxicity in the Cancer Patient 
  Davies, M, inPractice Cancer
  http://www.inpractice.com
  1/1/2013
• Nephrotoxicity in the Cancer Patient 
  Davies, M, inPractice Cancer
  http://www.inpractice.com
  1/1/2013